Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
Authors
Keywords
Amikacin, Pharmacokinetics/pharmacodynamics, Severe sepsis/septic shock
Journal
Annals of Intensive Care
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-02
DOI
10.1186/s13613-016-0211-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutablePseudomonas aeruginosa
- (2016) Vanessa E. Rees et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia
- (2015) O. Pajot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis
- (2015) Claire Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs
- (2015) Alexis Tabah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen
- (2014) Etienne de Montmollin et al. INTENSIVE CARE MEDICINE
- Aminoglycosides in Septic Shock
- (2013) Alexandre Boyer et al. DRUG SAFETY
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring
- (2012) MEDECINE ET MALADIES INFECTIEUSES
- Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity
- (2011) Ricardo Gálvez et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
- (2010) Anand Kumar et al. CRITICAL CARE MEDICINE
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
- (2010) Anand Kumar et al. CRITICAL CARE MEDICINE
- Severity of Gentamicin's Nephrotoxic Effect on Patients with Infective Endocarditis: A Prospective Observational Cohort Study of 373 Patients
- (2008) Kristine Buchholtz et al. CLINICAL INFECTIOUS DISEASES
- Do we still need the aminoglycosides?
- (2008) Emanuele Durante-Mangoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoglycoside drugs in clinical practice: an evidence-based approach
- (2008) Leonard Leibovici et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- -Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres)
- (2008) V. Dubois et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started